Urologix (ULGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2009 | 06-2008 | 06-2007 | 06-2006 | 06-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,419 | -14,897 | -13,237 | 5,494 | 2,837 |
| Depreciation Amortization | 973 | 1,191 | 2,260 | 2,014 | 1,881 |
| Income taxes - deferred | N/A | -1,519 | 4,842 | -4,476 | 294 |
| Accounts receivable | 256 | 2,190 | 1,105 | -1,010 | -1,617 |
| Accounts payable and accrued liabilities | -312 | -174 | -427 | -158 | 584 |
| Other Working Capital | -1,019 | 2,943 | 466 | -3,155 | -2,156 |
| Other Operating Activity | 600 | 9,221 | 6,487 | 2,458 | 1,096 |
| Operating Cash Flow | $-3,921 | $-1,045 | $1,496 | $1,167 | $2,919 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -86 | -213 | -312 | -953 | -91 |
| Sale Of Investment | N/A | N/A | N/A | 172 | 2,281 |
| Investing Cash Flow | $-86 | $-213 | $-312 | $-781 | $2,190 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -104 |
| Common Stock Issued | 8 | 39 | 12 | 69 | 452 |
| Financing Cash Flow | $8 | $39 | $12 | $69 | $348 |
| Beginning Cash Position | 11,031 | 12,250 | 11,054 | 10,599 | 5,142 |
| End Cash Position | 7,032 | 11,031 | 12,250 | 11,054 | 10,599 |
| Net Cash Flow | $-3,999 | $-1,219 | $1,196 | $455 | $5,457 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,921 | -1,045 | 1,496 | 1,167 | 2,919 |
| Capital Expenditure | -86 | -213 | -312 | -953 | -91 |
| Free Cash Flow | -4,007 | -1,258 | 1,184 | 214 | 2,828 |